Terms: = Head and neck cancer AND TSHR, hTSHR-I, 7253, ENSG00000165409, MGC75129, LGR3
285 results:
1. A Novel tshr Gene Mutation in a Family with Non-autoimmune Hyperthyroidism.
Kufoof T; Luxford C; Kannangara K; Clifton-Bligh R; Donaghue KC
Med Arch; 2024; 78(2):154-158. PubMed ID: 38566871
[TBL] [Abstract] [Full Text] [Related]
2. The relationship between subclinical hypothyroidism and invasive papillary thyroid cancer.
Li C; Zhang J; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1294441. PubMed ID: 38174330
[TBL] [Abstract] [Full Text] [Related]
3. Establishment and Characterization of Amitrole-Induced Mouse Thyroid Adenomatous Nodule-Derived Cell Lines.
Shirai YT; Hoshi N; Ward JM; Liu H; Cachau RE; Lee MP; Kimura S
Thyroid; 2024 Apr; 34(4):496-509. PubMed ID: 38149583
[No Abstract] [Full Text] [Related]
4. Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results.
Kyrilli A; Tacelli N; Russo L; Lebrun L; Salmon I; Russ G; Moreno-Reyes R; Corvilain B
Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37992294
[TBL] [Abstract] [Full Text] [Related]
5. Thyroid-stimulating hormone receptor (tshr) as a target for imaging differentiated thyroid cancer.
Gimblet GR; Whitt J; Houson HA; Lin D; Guenter R; Rao TC; Wang D; Ness J; Gonzalez ML; Murphy MS; Gillis A; Chen H; Copland JA; Kenderian SS; Lloyd RV; Szkudlinski MW; Lapi SE; Jaskula-Sztul R
Surgery; 2024 Jan; 175(1):199-206. PubMed ID: 37919223
[TBL] [Abstract] [Full Text] [Related]
6. The effect of acromegaly on thyroid disease.
Mo C; Zhong L
Endocr J; 2023 Nov; 70(11):1051-1060. PubMed ID: 37880078
[TBL] [Abstract] [Full Text] [Related]
7. Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment.
Gillis A; Zheng-Pywell R; McLeod C; Wang D; Ness JM; Guenter R; Whitt J; Prolla TA; Chen H; Gonzalez ML; Rose B; Lloyd RV; Jaskula-Sztul R; Lin D
Mod Pathol; 2023 Dec; 36(12):100332. PubMed ID: 37716507
[TBL] [Abstract] [Full Text] [Related]
8. Organochlorine pesticides and epigenetic alterations in thyroid tumors.
Salimi F; Asadikaram G; Ashrafi MR; Zeynali Nejad H; Abolhassani M; Abbasi-Jorjandi M; Sanjari M
Front Endocrinol (Lausanne); 2023; 14():1130794. PubMed ID: 37560303
[TBL] [Abstract] [Full Text] [Related]
9. Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery.
Yang X; Wu Y; Xu S; Li H; Peng C; Cui X; Dhoomun DK; Wang G; Xu T; Dong M; Li X; Du Y
BMC Endocr Disord; 2023 May; 23(1):113. PubMed ID: 37208644
[TBL] [Abstract] [Full Text] [Related]
10. Unraveling the significance of tshr mutations in indeterminate thyroid cytology specimens.
Andrianus S; Gubbiotti MA; Mandel SJ; Nikiforov YE; Baloch Z
Diagn Cytopathol; 2023 Jul; 51(7):406-413. PubMed ID: 37042127
[TBL] [Abstract] [Full Text] [Related]
11. Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations.
Whitmer D; Phay JE; Holt S; O'Donnell B; Nguyen J; Joseph D; Chi A; Wu S; Hao Y; Huang J; Klopper JP; Kloos RT; Kennedy GC; Shin J
Front Endocrinol (Lausanne); 2022; 13():1073592. PubMed ID: 36619548
[TBL] [Abstract] [Full Text] [Related]
12. Prospects of Testing Diurnal Profiles of Expressions of TSH-R and Circadian Clock Genes in Thyrocytes for Identification of Preoperative Biomarkers for Thyroid Carcinoma.
Putilov A
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293065
[TBL] [Abstract] [Full Text] [Related]
13. Thyrotropin receptor antagonists and inverse agonists, and their potential application to thyroid diseases.
Nagayama Y; Nishihara E
Endocr J; 2022 Nov; 69(11):1285-1293. PubMed ID: 36171093
[TBL] [Abstract] [Full Text] [Related]
14. Sinomenine Hydrochloride Promotes tshr-Dependent Redifferentiation in Papillary Thyroid cancer.
Zhang J; Zhao A; Jia X; Li X; Liang Y; Liu Y; Xie X; Qu X; Wang Q; Zhang Y; Gao R; Yu Y; Yang A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142613
[TBL] [Abstract] [Full Text] [Related]
15. Potential values of circulating tumor cell for detection of recurrence in patients of thyroid cancer: a diagnostic meta-analysis.
Liang MX; Fei YJ; Yang K; Tang WJ; Cao XH; Tang JH
BMC Cancer; 2022 Sep; 22(1):954. PubMed ID: 36064384
[TBL] [Abstract] [Full Text] [Related]
16. Indeterminate Thyroid Fine-Needle Aspirations in Pediatrics: Exploring Clinicopathologic Features and Utility of Molecular Profiling.
Baran JA; Halada S; Bauer AJ; Ricarte-Filho JC; Isaza A; Surrey LF; McGrath C; Bhatti T; Jalaly J; Mostoufi-Moab S; Franco AT; Adzick NS; Kazahaya K; Cahill AM; Baloch Z
Horm Res Paediatr; 2022; 95(5):430-441. PubMed ID: 35871517
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of the Molecular Landscape of Pediatric Thyroid Nodules and Use of a Multigene Genomic Classifier in Children.
Gallant JN; Chen SC; Ortega CA; Rohde SL; Belcher RH; Netterville JL; Baregamian N; Wang H; Liang J; Ye F; Nikiforov YE; Nikiforova MN; Weiss VL
JAMA Oncol; 2022 Sep; 8(9):1323-1327. PubMed ID: 35679040
[TBL] [Abstract] [Full Text] [Related]
18. Management of Graves' hyperthyroidism: present and future.
Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
[TBL] [Abstract] [Full Text] [Related]
19. TSH-tshr axis promotes tumor immune evasion.
Wu Z; Xi Z; Xiao Y; Zhao X; Li J; Feng N; Hu L; Zheng R; Zhang N; Wang S; Huang T
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101946
[TBL] [Abstract] [Full Text] [Related]
20. The risk factors for Graves' ophthalmopathy.
Cao J; Su Y; Chen Z; Ma C; Xiong W
Graefes Arch Clin Exp Ophthalmol; 2022 Apr; 260(4):1043-1054. PubMed ID: 34787691
[TBL] [Abstract] [Full Text] [Related]
[Next]
